StockData

Cerenome vs Tenon Medical

CNSY and TNON side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CNSY and TNON compare

Cerenome is the larger company, worth 5.7 times as much as Tenon Medical ($4.8M against $834K).

Tenon Medical grew revenue faster over the last twelve months (80.3% versus −21.0% for Cerenome).

Tenon Medical keeps more of each dollar of sales as profit, with a net margin of −258% compared with −621% at Cerenome.

Tenon Medical scores higher on the StockData Score (9 against 8 for Cerenome), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCNSYTNON
Size and price
Market cap$4.8M$834K
Share price$0.630$1.25
Change, 1 year−95.1%−97.0%
Change, 5 years−98.3%–
Beta (5Y)4.92−1.40
Employees2826
StockData Score
Total score89 (better)
Valuation score3 (better)1
Growth score13 (better)
Performance score01 (better)
Health score44
Dividend score00
Valuation
P/S1.1×0.2× (better)
P/B0.9×–
FCF yield−492% (better)−1448%
Fair value$2.14–
Margin of safety70.5%–
Growth
Revenue growth (TTM)−21.0%80.3% (better)
Profitability
Gross margin–66.8%
Operating margin−628%−243% (better)
Net margin−621%−258% (better)
FCF margin−560%−227% (better)
Return on equity−614%−551% (better)
Financial health
Debt / equity0.00–
Interest coverage−1200.0×–
Current ratio1.37 (better)0.58
Altman Z-score−58.37−16.67 (better)
Piotroski F-score44
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions8.3%–
Held by insiders4.2%–
Insider net buying, 12 months$0 (better)−$105K
Short interest, % of float11.6%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.